000 01192 a2200361 4500
005 20250514065901.0
264 0 _c20030529
008 200305s 0 0 eng d
022 _a1474-1776
024 7 _a10.1038/nrd1085
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKhurana, Tejvir S
245 0 0 _aPharmacological strategies for muscular dystrophy.
_h[electronic resource]
260 _bNature reviews. Drug discovery
_cMay 2003
300 _a379-90 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAnimals
650 0 4 _aCalcium
_xmetabolism
650 0 4 _aCytoskeletal Proteins
_xgenetics
650 0 4 _aDisease Models, Animal
650 0 4 _aDrug Design
650 0 4 _aDrug Evaluation, Preclinical
650 0 4 _aDystrophin
_xgenetics
650 0 4 _aHomeostasis
650 0 4 _aHumans
650 0 4 _aMembrane Proteins
_xgenetics
650 0 4 _aMuscular Dystrophies
_xdrug therapy
650 0 4 _aPromoter Regions, Genetic
650 0 4 _aUtrophin
700 1 _aDavies, Kay E
773 0 _tNature reviews. Drug discovery
_gvol. 2
_gno. 5
_gp. 379-90
856 4 0 _uhttps://doi.org/10.1038/nrd1085
_zAvailable from publisher's website
999 _c12539016
_d12539016